HBI Deals+Insights / Digital and AI

Chinese genetic testing firm receives US$20m investment

Chinese genetic testing company Nuhui Health, which specialises in cancer screening, has received US$20m from five different investors in order to launch AI-based early screening technology.

We would welcome your thoughts on this story. Email your views to Ariane Jugieux or call 0207 183 3779.